Their findings indicated that fetuses of mothers with GDM who were undergoing insulin therapy exhibited a decreased CC length (35.54 mm) compared to both the control group (40 mm; p < 0.001) and the group of women with GDM managed through diet alone (39.26 mm; p = 0.022). The gene discussed is INS; the disease is gestational diabetes.